- Global incidence and prevalence of nonalcoholic fatty liver disease
-
Teng ML, Ng CH, Huang DQ, Chan KE, Tan DJ, Lim WH, Yang JD, Tan E, Muthiah MD
- KMID: 2539788
- Clin Mol Hepatol.
- 2023 Feb;29(Suppl):S32-S42.
- doi: 10.3350/cmh.2022.0365
Nonalcoholic fatty liver disease (NAFLD) is a leading cause of liver disease worldwide. The estimated global incidence of NAFLD is 47 cases per 1,000 population and is higher among males... -
- CITED
-
- Close
- SHARE
-
- Close
- Global prevalence of depression and anxiety in patients with hepatocellular carcinoma: Systematic review and meta-analysis
-
Tan DJH, Quek SXZ, Yong JN, Suresh A, Koh KXM, Lim WH, Quek J, Tang A, Tan C, Nah B, Tan E, Keitoku T, Muthiah MD, Syn N, Ng CH, Kim BK, Tamaki N, Ho CSH, Loomba R, Huang DQ
- KMID: 2534351
- Clin Mol Hepatol.
- 2022 Oct;28(4):864-875.
- doi: 10.3350/cmh.2022.0136
Background/Aims: Depression and anxiety are associated with poorer outcomes in patients with hepatocellular carcinoma (HCC). However, the prevalence of depression and anxiety in HCC are unclear. We aimed to establish... -
- CITED
-
- Close
- SHARE
-
- Close
